SCHEMBL357360

SCHEMBL357360

[CH2]C(C)(C)N(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28321756 0.76
SCHEMBL11375024 0.76
SCHEMBL11064163 0.73
SCHEMBL27579909 0.73
SCHEMBL9131757 0.70
SCHEMBL124148 0.67
SCHEMBL23452016 0.67
SCHEMBL10877897 0.67
SCHEMBL11877968 0.67
SCHEMBL8333139 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102757422-B The derivative of N-[(1H-pyrazol-1-yl) aryl]-1H-indoles or 1H-indazole-3-methane amide, its preparation method and application in the treatment thereof SAI NUOFEI (FR) 2015-09-16 CN claimed
EP-2702056-A1 DERIVATIVES OF N- [(1H-PYRAZOL-1-YL) ARYL]- 1H - INDOLE OR 1H - INDAZOLE - 3 - CARBOXAMIDE, THEIR PREPARATION AND THEIR USE AS P2Y12 ANTAGONISTS Sanofi (FR) 2014-03-05 EP claimed
EP-2518067-B1 DERIVATIVES OF N-[(1H-PYRAZOL-1-YL)ARYL]-1H-INDOLE OR 1H- INDAZOLE-3-CARBOXAMIDE AND THEIR THERAPEUTIC USES AS P2Y12 ANTAGONISTS SANOFI SA (FR) 2014-03-05 EP claimed
CN-103619834-A Derivatives of N-[(1H-pyrazol-1-yl)aryl]-1H-indole or 1H-indazole-3-carboxamide, their preparation and their use as P2Y12 antagonists SANOFI SA 2014-03-05 CN claimed
EP-2507308-B1 HYDROLYTICALLY STABLE MULTI-PURPOSE POLYMERS LUBRIZOL ADVANCED MAT INC (US) 2014-02-12 EP claimed
US-8623862-B2 Derivatives of N-[(1H-pyrazol-1-yl)aryl]-1H-indole or 1H-indazole-3-carboxamide, preparation thereof and applications thereof in therapeutics SANOFI (FR) 2014-01-07 US claimed
WO-2012146318-A1 DERIVATIVES OF N- [(1H-PYRAZOL-1-YL) ARYL] - 1H - INDOLE OR 1H - INDAZOLE - 3 - CARBOXAMIDE, THEIR PREPARATION AND THEIR USE AS P2Y12 ANTAGONISTS SANOFI (FR) 2012-11-01 WO claimed
US-20120277205-A1 DERIVATIVES OF N-[(1H-PYRAZOL-1-YL)ARYL]-1H-INDOLE OR 1H-INDAZOLE-3-CARBOXAMIDE, PREPARATION THEREOF AND APPLICATIONS THEREOF IN THERAPEUTICS SANOFI (FR) 2012-11-01 US claimed
EP-2518067-A1 Derivatives of N-[(1H-pyrazol-1-YL)aryl]-1H-indole or 1H- indazole-3-carboxamide and their therapeutic uses as P2Y12 antagonists SANOFI (FR) 2012-10-31 EP claimed
CN-102757422-A Derivatives of N-[(1H-pyrazol-1-yl)aryl]-1H-indole or 1H- indazole-3-carboxamide and their therapeutic uses as p2y12 antagonists SANOFI SA 2012-10-31 CN claimed
US-7301028-B2 Mitotic kinesin inhibitors MERCK & CO., INC. (US) 2007-11-27 US claimed
EP-1515949-B1 MITOTIC KINESIN INHIBITORS MERCK & CO INC (US) 2007-03-14 EP claimed
US-20060063942-A1 Mitotic kinesin inhibitors MERCK SHARP & DOHME CORP. 2006-03-23 US claimed
EP-1515949-A4 MITOTIC KINESIN INHIBITORS MERCK & CO INC (US) 2005-11-09 EP claimed
EP-1515949-A1 MITOTIC KINESIN INHIBITORS Merck & Co., Inc. (US) 2005-03-23 EP claimed
WO-2003106417-A1 MITOTIC KINESIN INHIBITORS MERCK & CO., INC. (US) 2003-12-24 WO claimed
WO-1994010142-A1 NEW SUBSTITUTED AZETIDINONES AS ANTI-INFLAMMATORY AND ANTIDEGENERATIVE AGENTS MERCK & CO., INC. (US) 1994-05-11 WO claimed
EP-3782986-B1 HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICALS CO (JP) 2024-07-10 EP disclosed
EP-0033965-A2 New cephem compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-08-19 EP disclosed
US-3959272-A ANALGESICS, ANTIINFLAMMATORY, PSYCHOTROPIC SOCIETE ANONYME DITE: HEXACHIME (FR) 1976-05-25 US disclosed